Institutional investors hold a majority ownership of PDLI through the 92.57% of the outstanding shares that they control. This interest is also higher than at almost any other company in the Biotechnology industry. Last, during the quarter ended June 2015, these large investors purchased a net $3.2 million shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
DANSKE BANK A/S (INVT MGMT) Bought 216.9 Thousand shares of PDL BioPharma Inc
FIRST ASSET INVESTMENT MANAGEMEN... Bought 71.6 Thousand shares of PDL BioPharma Inc
QUANTS VERMÖGENSMANAGEMENT AG Bought 46.9 Thousand shares of PDL BioPharma Inc